Metsera

Metsera EPS

Delisted

The Earnings per Share (EPS) of Metsera (MTSR) as of Nov 3, 2026 is -2.03 USD. In the previous year, Earnings per Share (EPS) was -0.95 USD — a change of 114.74% (lower).

EPS

-2.03USD

YoY

114.74%

Last updated:

Earnings per Share (EPS) of Metsera is 2024 -2.03 USD. Earnings per Share (EPS) of Metsera was 2023 -0.95 USD. It decreases by 114.74% lower compared to the previous year.

The Metsera EPS history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EPS
Date
EPS
Jan 1, 2022
-0.02 USD
Jan 1, 2023
-0.95 USD
Jan 1, 2024
-2.03 USD
Jan 1, 2025 (e)
-2.78 USD
Jan 1, 2028 (e)
-3.80 USD
Jan 1, 2029 (e)
-4.92 USD
The Metsera EPS history
YEAREPSYoY
est-4.92USD+29.47%
est-3.80USD+36.94%
est-2.78USD+36.72%
-2.03USD+114.74%
-0.95USD+5,706.39%
-0.02USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Metsera Stock analysis

What does Metsera do? Metsera Inc. is a clinical stage biopharmaceutical company based in New York City, operating in the Health Care sector with a focus on Biotechnology. The company develops next-generation injectable and oral nutrient stimulated hormone (NuSH) analog peptides for treating obesity and related conditions. Utilizing its proprietary MINT peptide library, HALO half-life extension platform, and MOMENTUM oral delivery system, Metsera has a pipeline including MET-097i, MET-233i, and MET-224o, targeting various obesity treatments with differentiated approaches. Listed on 31 January 2025, the company employs 82 staff. Metsera is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Metsera stock

Earnings per Share (EPS) of Metsera is -2.03 USD in 2024.

Earnings per Share (EPS) of Metsera changed from -0.95 USD to -2.03 USD, representing a 114.74% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Earnings per Share (EPS) Metsera since 2006 – with annual values, charts, and detailed analysis.

Earnings per Share measures the portion of a company's profit allocated to each outstanding share. It is a key metric for assessing a company's profitability on a per-share basis.

EPS = Net Income / Shares Outstanding

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Metsera

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Metsera